PMID- 31336911 OWN - NLM STAT- MEDLINE DCOM- 20191227 LR - 20200225 IS - 1422-0067 (Electronic) IS - 1422-0067 (Linking) VI - 20 IP - 14 DP - 2019 Jul 12 TI - Glucagon-Like Peptide-1 Receptor Agonist Attenuates Autophagy to Ameliorate Pulmonary Arterial Hypertension through Drp1/NOX- and Atg-5/Atg-7/Beclin-1/LC3beta Pathways. LID - 10.3390/ijms20143435 [doi] LID - 3435 AB - Mitochondrial dysfunction is associated with cardiovascular diseases and diabetes. Pulmonary arterial hypertension (PAH) is characterized by pulmonary vascular remodeling, and the abnormal proliferation, apoptosis and migration of pulmonary arterial smooth muscle cells (PASMCs). The glucagon-like peptide-1 (GLP-1) receptor agonist, liraglutide, has been shown to prevent pulmonary hypertension in monocrotaline-exposed rats. The aim of this study was to investigate the effect of liraglutide on autophagy, mitochondrial stress and apoptosis induced by platelet-derived growth factor BB (PDGF-BB). PASMCs were exposed to PDGF-BB, and changes in mitochondrial morphology, fusion-associated protein markers, and reactive oxygen species (ROS) production were examined. Autophagy was assessed according to the expressions of microtubule-associated protein light chain 3 (LC3)-II, LC3 puncta and Beclin-1. Western blot analysis was used to assess apoptosis, mitochondrial stress and autophagy markers. Liraglutide significantly inhibited PDGF-BB proliferation, migration and motility in PASMCs. PDGF-BB-induced ROS production was mitigated by liraglutide. Liraglutide increased the expression of alpha-smooth muscle actin (alpha-SMA) and decreased the expression of p-Yes-associated protein (p-YAP), inhibited autophagy-related protein (Atg)-5, Atg-7, Beclin-1 and the formation of LC3-beta and mitochondrial fusion protein dynamin-related (Drp)1. Therefore, liraglutide can mitigate the proliferation of PASMCs via inhibiting cellular Drp1/nicotinamide adenine dinucleotide phosphate (NADPH) oxidases (NOX) pathways and Atg-5/Atg-7/Beclin-1/LC3beta-dependent pathways of autophagy in PAH. FAU - Wu, Yi-Chia AU - Wu YC AD - Division of Plastic Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung 80708, Taiwan. AD - Ph.D. Program in Translational Medicine, Kaohsiung Medical University and Academia Sinica, Taipei 11564, Taiwan. AD - Research Center of Regenerative Medicine and Cell Therapy, Kaohsiung Medical University, Kaohsiung 80708, Taiwan. AD - Translational Research Center, Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung 80708, Taiwan. FAU - Wang, Wei-Ting AU - Wang WT AD - Center of Teaching and Research, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung 80145, Taiwan. FAU - Lee, Su-Shin AU - Lee SS AD - Division of Plastic Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung 80708, Taiwan. AD - Research Center of Regenerative Medicine and Cell Therapy, Kaohsiung Medical University, Kaohsiung 80708, Taiwan. AD - Department of Surgery, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan. FAU - Kuo, Yur-Ren AU - Kuo YR AD - Division of Plastic Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung 80708, Taiwan. AD - Research Center of Regenerative Medicine and Cell Therapy, Kaohsiung Medical University, Kaohsiung 80708, Taiwan. AD - Department of Surgery, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan. FAU - Wang, Ya-Chin AU - Wang YC AD - Division of Plastic Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung 80708, Taiwan. FAU - Yen, Shih-Jung AU - Yen SJ AD - Department of Internal Medicine, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung 80145, Taiwan. AD - Division of Endocrinology and Metabolism, Department of Internal Medicine, Kaohsiung Medical University Hospital, 807 Kaohsiung 80708, Taiwan. FAU - Lee, Mei-Yueh AU - Lee MY AUID- ORCID: 0000-0001-8950-064X AD - Division of Endocrinology and Metabolism, Department of Internal Medicine, Kaohsiung Medical University Hospital, 807 Kaohsiung 80708, Taiwan. lovellelee@hotmail.com. AD - Department of Pharmacology, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan. lovellelee@hotmail.com. FAU - Yeh, Jwu-Lai AU - Yeh JL AUID- ORCID: 0000-0001-7101-5865 AD - Department of Pharmacology, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan. jwulai@kmu.edu.tw. AD - Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung 80708, Taiwan. jwulai@kmu.edu.tw. LA - eng GR - MOST 106-2314-B-650-009 and MOST 106-2320-B-037-010-MY3/Ministry of Science and Technology/ GR - KMTTH-104-033 and KMTTH -106-041/Kaohsiung Municipal Ta-Tung Hospital/ GR - AS-TM-108-02-01/Translational Medical Research Program of Academia Sinica, Taiwan/ PT - Journal Article DEP - 20190712 PL - Switzerland TA - Int J Mol Sci JT - International journal of molecular sciences JID - 101092791 RN - 0 (Glucagon-Like Peptide-1 Receptor) RN - 0 (Reactive Oxygen Species) RN - 1B56C968OA (Becaplermin) RN - 839I73S42A (Liraglutide) SB - IM MH - Animals MH - Apoptosis/drug effects MH - Autophagy/*drug effects MH - Becaplermin/metabolism MH - Cell Movement/drug effects MH - Cell Proliferation/drug effects MH - Glucagon-Like Peptide-1 Receptor/*agonists MH - Liraglutide/pharmacology MH - Male MH - Mitochondria/drug effects/metabolism MH - Mitochondrial Dynamics/drug effects MH - Models, Biological MH - Muscle, Smooth, Vascular/cytology/metabolism MH - Myocytes, Smooth Muscle/drug effects/metabolism MH - Pulmonary Arterial Hypertension/drug therapy/*etiology/*metabolism MH - Rats MH - Reactive Oxygen Species/metabolism MH - Signal Transduction/*drug effects PMC - PMC6678531 OTO - NOTNLM OT - GLP-1 receptor agonists OT - autophagy OT - liraglutide OT - mitochondria OT - pulmonary artery hypertension COIS- The authors declare no conflict of interest. EDAT- 2019/07/25 06:00 MHDA- 2019/12/28 06:00 PMCR- 2019/07/01 CRDT- 2019/07/25 06:00 PHST- 2019/06/27 00:00 [received] PHST- 2019/07/09 00:00 [revised] PHST- 2019/07/11 00:00 [accepted] PHST- 2019/07/25 06:00 [entrez] PHST- 2019/07/25 06:00 [pubmed] PHST- 2019/12/28 06:00 [medline] PHST- 2019/07/01 00:00 [pmc-release] AID - ijms20143435 [pii] AID - ijms-20-03435 [pii] AID - 10.3390/ijms20143435 [doi] PST - epublish SO - Int J Mol Sci. 2019 Jul 12;20(14):3435. doi: 10.3390/ijms20143435.